Apomorphine in the treatment of Parkinson's disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.12, 2007-08, pp. : 1941-1950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apomorphine in the treatment of Parkinson disease and other movement disorders

By Gunzler Steven A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1027-1038

Informa Healthcare

Access to resources Recommend Favorite

Apomorphine therapy in Parkinson's disease: a review

By Ul Haq Ihtsham Lewitt Peter A Fernandez Hubert H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2799-2809

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson's Disease

By Neef C.

Clinical Pharmacokinetics, Vol. 37, Iss. 3, 1999-09 ,pp. : 257-271

Adis International

Access to resources Recommend Favorite

Subcutaneous Apomorphine: An Evidence-Based Review of its Use in Parkinsons Disease

By Dirk Deleu

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 687-709

Adis International

Access to resources Recommend Favorite

Safinamide in the treatment of Parkinson's disease

By Schapira Anthony HV

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2261-2268

Informa Healthcare

Access to resources Recommend Favorite